Company Overview

Talus Bioscience is a Seattle-based drug discovery company that uses AI-powered MARMOT platform technology to develop therapeutics targeting transcription factors and previously undruggable cancer targets. The YC W21 company raised $11.2M in Seed+ funding in August 2024, achieved FDA and EMA approval for Phase I human trials of lead program MSD-001 in 2024, and measures over 10,000 regulomes per month using live unmodified human cells. Talus serves pharmaceutical companies and research institutions with novel approaches to difficult-to-treat cancers.

Revenue
$11.2M
Loading News...
Loading Timeline...
Loading Culture...
Loading Leadership...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Emerging Innovator

Talus Bio is an emerging player bringing innovative solutions to the Healthcare market.

Frequently Asked Questions

AI Visibility Rankings

How Talus Bio performs in AI search results

AI Rank
?
Track your position
Platforms
5
ChatGPT, Gemini, Claude...
Visibility
?
Your mention rate
Premium Feature

Unlock AI Visibility Tracking for Talus Bio

See exactly how Talus Bio ranks across ChatGPT, Gemini, Perplexity, Claude, and Grok. Get actionable insights to improve your AI search performance.

Real-time Rankings
Track your position daily
Competitive Intel
See how you compare
Platform Breakdown
Per-AI performance
Actionable Insights
Optimize your visibility
Start Tracking for Free

Join 1,000+ brands · Free 7-day trial · No credit card required

Want to improve your AI visibility? Track performance across all major AI platforms.
Compare with Other Brands

Compare with Other Brands

See how Talus Bio stacks up against competitors with our detailed comparison tool.

Start Comparison